Biogen, Eisai Get FDA Nod for Leqembi IV Maintenance Dosing
Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA approved the maintenance dosing of once every four weeks after 18 months of the initiation phase of once every two weeks.
Discover what FDA's red dye ban means for your food safety. Learn which synthetic colors remain in your favorite foods and ...
1don MSN
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
The Trump administration has withdrawn the proposed rule that would ban menthol in cigarettes and flavored cigars according ...
3don MSN
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
In 2024, food recalls in the US seemed to soar. Between headline-making outbreaks of listeria and E. coli and problems with ...
Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external ...
MONDAY, Jan. 27, 2025 (HealthDay News) -- Reports of cats becoming seriously ill or dying after consuming raw pet food or milk tainted with the deadly bird flu virus have prompted the U.S. Food and ...
Hosted on MSN8h
Montana bill seeks state panel on food safetyResearch shows toxic additives have been overlooked in the U.S. food supply, though the federal Food and Drug Administration ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback